Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

Today, 9:38 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11)

ABSI

8 minute read

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

By Shanthi Rexaline

Today, 9:38 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)

ABIO

4 minute read

45 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:38 AM

Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.

AEHR

1 minute read

‘Re: $FMTX today, there’s a precedent for an experimental cancer drug being linked to potential diabetes risk. Who remembers $CLVS, roci and the 2014 ASCO meeting…’ -Tweet From STAT News’ Adam Feuerstein

By Benzinga Newsdesk

Today, 9:38 AM

https://twitter.com/adamfeuerstein/status/1446125329915912192

FMTX

7 minute read

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

By Shanthi Rexaline

Today, 9:38 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)

ADVM

3 minute read

Forma Therapeutics’ FT-7051 Is Well-tolerated And Demonstrates Evidence If Activity In Initial Results From Ongoing Phase 1 Courage Study In Men With Metastatic Castration-resistant Prostate Cancer

By Benzinga Newsdesk

Today, 9:38 AM

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today announced positive

FMTX

4 minute read